• The SEC letter regained traction, keeping DeFi-friendly regulation in focus. • Injective climbed into the top 10 RWAs with a $1.1B market cap and 2.4% market share. • Injective remained a top 5 chain by net inflows, surpassing $250M bridged YTD. • Excitement for the Injective Summit keeps growing with major industry names joining. • ChoiceXchange introduced Concentrated Liquidity for more efficient LP strategies. • Injective took the CLARITY Act discussion to CNBC, advocating for regulatory clarity.